I made this announcement to 63,919 members of the Digital Health group on LinkedIn. If you’re on LinkedIn, please do join the group, which allows you to opt in to receiving these announcements in addition to connecting with thousands of other global stakeholders in digital health. I also send out a weekly Fourth Wave: Digital Health Newsletter, which you can sign up for and receive for free, here.
The Fourth Wave: Digital Health Update ⋅ Paul Sonnier ⋅ July 19, 2018 ⋅ #335
Announcement to 63,919 Digital Health Group Members
Dear Group,
My newsletter for July 18th is viewable below or here (with images).
Subscribe here.
BOOK
My book, “The Fourth Wave: Digital Health” is available in digital and paperback at Amazon.com, here. You can also learn more about the book, here.
TWITTER
Follow me on Twitter @Paul_Sonnier for all the news I share each day.
SERVICES
I’m available to deliver my keynote address at conferences and corporate events. I also offer event and entity advertising in my group announcements, newsletter, and on my website. Advertising with me puts your event, content, product, and/or service in front of tens of thousands of global readers each week. I’m also available for strategic consulting. Contact me for my media kit, standard plans, and pricing.
CALENDAR OF GLOBAL EVENTS
All events are viewable, filterable, and searchable here.
There are no featured events at this time.
EVENT PROMOTION
Please contact me for options on event promotion, including having your event featured at the top of this list, featured in my weekly Digital Health group announcements, newsletter, and on Twitter.
SUBMITTING AN EVENT
Please provide the event name, date(s), event website link (direct and not a shortened url), one-paragraph event description, the venue name, and location (city and country). Not all events are relevant to digital health and webinars are typically not allowed, but you can ask me about promotion options.
—————————————- BEGIN NEWSLETTER —————————————-
The Fourth Wave: Digital Health Newsletter for Jul 18
The Nuffield Council on Bioethics (NCB), a UK-based charitable organization focused on bioethical issues related to biological and medical research has deemed that editing the DNA of a human embryo, sperm, or egg to influence the characteristics of a future person — aka ‘heritable genome editing’ — could be morally permissible. One example they cite is excluding a heritable disease or a predisposition to cancer in later life. The NCB recommends that these efforts should secure the welfare of the future person and not increase disadvantage, discrimination, or division in society
A new study, published in JAMA indicates that there is an association ofdigital media use (e.g. social media and watching online video) with subsequent symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) among adolescents. According to lead study author Adam Leventhal: “If we can determine if there is a potential causal link that is consistent across studies, then we can design interventions to curb media exposure. Even simple educational information to let teachers, parents, and pediatric health professionals know that there could be an increased risk when they talk with their teens about digital media use might be helpful.”
PRODUCT RECALL
Ortovox has recalled 20,000 of its “ORTOVOX 3+” avalanche transceivers deemed to be unsafe due to a software issue that can result in the “temporary disruption of the transmission function.” The company states that: “Devices affected by the recall may no longer be used without the required software update to version 2.2. This precautionary recall applies exclusively to ORTOVOX 3+ avalanche transceivers running software version 2.1 – no matter what color.”
FDA CLEARANCE
Zebra Medical has obtained FDA clearance for its AI-powered heart disease detection system. According to Dr. Ran Balicer at Clalit Research Institute: “Identification of high-risk individuals is key to prevention. Zebra’s algorithm could run on CT studies of the chest and potentially help identify people with cardiovascular risk sooner, allowing more effective treatment and overall reduction of adverse outcomes and healthcare costs for HMOs such as Clalit.”
FUNDING
Verge Genomics has raised $32 million. The company uses AI to speed up the drug development process and has a particular focus on therapies for Parkinsons and ALS, which it plans to test in humans several years from now.
Spring Health has raised $6 million. The company offers a predictive AI service that analyzes clinical trials and real-world evidence to match patients to mental health therapies and other treatments.
GENOMICS
A new study published in Nature states that repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements of DNA bases that could produce negative health outcomes in recipients of CRISPR-based therapies.
—————————————- END NEWSLETTER —————————————-
FEATURED EVENTS
None at this time.
EVENT PROMOTION
Please contact me for options on event promotion, including having your event featured at the top of this list, featured in my weekly Digital Health group announcements, newsletter, and on Twitter.
SUBMITTING AN EVENT
Please provide the event name, date(s), event website link (direct and not a shortened url), one-paragraph event description, the venue name, and location (city and country). Not all events are relevant to digital health and webinars are typically not allowed, but you can ask me about promotion options.
Copyright © 2018 Paul Sonnier, Story of Digital Health
Paul Sonnier
Author ⋅ Speaker ⋅ Technologist ⋅ Social Entrepreneur
Book: The Fourth Wave: Digital Health
Founder, Digital Health group on LinkedIn
Creator, Story of Digital Health
Twitter: @Paul_Sonnier
San Diego, CA, USA
The post The Fourth Wave: Digital Health Update ⋅ Paul Sonnier ⋅ July 20, 2018 ⋅ #335 appeared first on Paul Sonnier - Story of Digital Health.
from Paul Sonnier – Story of Digital Health https://storyofdigitalhealth.com/the-fourth-wave-digital-health-update-paul-sonnier-july-19-2018-335/
via IFTTT
No comments:
Post a Comment